Enter Symbol:
THE QUIGLEY CORPORATION
Drug Delivery
QGLY @ Yahoo Finance QGLY Option @ Yahoo Finance
Stock Details
Current Price	High	Value Change	Percent Change	Dividend	Previous Close
$ 1.85	$ 1.95	$ -0.07	-1.67%	0.00	$ 1.92
Opening Price	Low	Volume	Market Cap	Average Volume	P/E
$ 1.87	$ 1.85	3,820	26.88M	5,516	-6.17
Pivot Table
R2 R1 Pivot S1 S2 1.98 1.91 1.88 1.81 1.78

The Quigley Corporation engages in the development, manufacture, and distribution of homeopathic and health products. It operates in four segments: Cold Remedy, Health and Wellness, Contract Manufacturing, and Ethical Pharmaceutical. The Cold Remedy segment offers Cold-Eeze, a zinc gluconate glycine formulation. Cold-Eeze is an over-the-counter consumer product used to reduce the duration and severity of the common cold; and is sold in lozenge, sugar-free tablet, and gum forms. The Health and Wellness segment specializes in the development and distribution of proprietary health and wellness products, including herbal vitamins and dietary supplements for the human condition, primarily within the United States. The Contract Manufacturing segment produces lozenge product. It warehouses and ships the company's Cold-Eeze products. This segment also produces a variety of hard and organic candy for sale to third party customers, as well as engages in contract manufacturing activities for nonrelated entities. The Ethical Pharmaceutical segment involves in the research and development of naturally derived prescription drugs, cosmeceuticals, and dietary supplements. The Quigley was organized in 1989 by Guy J. Quigley and Charles A. Phillips. The company is headquartered in Doylestown, Pennsylvania.